Treating pediatric port-wine stains in aesthetics


      A port-wine stain (PWS) is a vascular birthmark present in 0.3% to 0.5% of newborns. If untreated, this erythematous patch will grow proportionally with the child to thicken and darken with age. PWSs have implications for the child’s quality of life for many years, with cosmetic, medical, and psychosocial disability. Controversy exists in many aspects surrounding laser treatment of these birthmarks in the pediatric population. We have reviewed the clinical features as well as the historic and current laser treatment of PWS. We have also examined the current hot topics of debate surrounding the treatment of PWS in the pediatric population. These controversies include the patient age of treatment initiation, the long-term psychologic impact, the use of general anesthesia, the application of eye shields, and alternative treatments for recalcitrant PWS. We have concluded with a discussion on the future directions of management and treatment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Waibel JS, Holmes J, Rudnick A, Woods D, Kelly KM. Angiographic optical coherence tomography imaging of hemangiomas and port wine birthmarks [e-pub ahead of print]. Lasers Surg Med. doi:10.1002/lsm.22816. Accsessed April, 2020.

        • Cordoro KM
        • Speetzen LS
        • Koerper MA
        • Frieden IJ.
        Physiologic changes in vascular birthmarks during early infancy: mechanisms and clinical implications.
        J Am Acad Dermatol. 2009; 60: 669-675
        • Jacobs AH
        • Walton RG.
        The incidence of birthmarks in the neonate.
        Pediatrics. 1976; 58: 218-222
        • Alper JC
        • Holmes LB.
        The incidence and significance of birthmarks in a cohort of 4,641 newborns.
        Pediatr Dermatol. 1983; 1: 58-68
        • Jeon H
        • Bernstein LJ
        • Belkin DA
        • Ghalili S
        • Geronemus RG.
        Pulsed dye laser treatment of port-wine stains in infancy without the need for general anesthesia.
        JAMA Dermatol. 2019; 155: 435-441
        • Shirley MD
        • Tang H
        • Gallione CJ
        • et al.
        Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
        N Engl J Med. 2013; 368: 1971-1979
        • Minkis K
        • Geronemus RG
        • Hale EK.
        Port wine stain progression: a potential consequence of delayed and inadequate treatment?.
        Lasers Surg Med. 2009; 41: 423-426
        • Passeron T
        • Salhi A
        • Mazer JM
        • et al.
        Prognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS).
        J Am Acad Dermatol. 2016; 75: 64-68
        • Geronemus RG
        • Ashinoff R.
        The medical necessity of evaluation and treatment of port-wine stains.
        J Dermatol Surg Oncol. 1991; 17: 76-79
        • Finley JL
        • Noe JM
        • Arndt KA
        • Rosen S.
        Port-wine stains. Morphologic variations and developmental lesions.
        Arch Dermatol. 1984; 120: 1453-1455
        • Mills CM
        • Lanigan SW
        • Hughes J
        • Anstey AV.
        Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of naevus anaemicus and results of prior treatment.
        Clin Exp Dermatol. 1997; 22: 166-168
        • Klapman MH
        • Yao JF.
        Thickening and nodules in port-wine stains.
        J Am Acad Dermatol. 2001; 44: 300-302
        • Enjolras O.
        • et al.
        Vascular malformations.
        in: Bolognia JLJJ Schaffer JV Dermatology. 3rd ed. Elsevier, London, United Kingdom2012
        • Geronemus RG.
        Argon laser for the treatment of cutaneous lesions.
        Clin Dermatol. 1995; 13: 55-58
        • Anderson RR
        • Parrish JA.
        Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation.
        Science. 1983; 220: 524-527
        • Dierickx CC
        • Casparian JM
        • Venugopalan V
        • Farinelli WA
        • Anderson RR.
        Thermal relaxation of port-wine stain vessels probed in vivo: the need for 1-10-millisecond laser pulse treatment.
        J Invest Dermatol. 1995; 105: 709-714
        • Chang CJ
        • Nelson JS.
        Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage.
        Dermatol Surg. 1999; 25: 767-772
        • Waldorf HA
        • Alster TS
        • McMillan K
        • Kauvar AN
        • Geronemus RG
        • Nelson JS.
        Effect of dynamic cooling on 585-nm pulsed dye laser treatment of port-wine stain birthmarks.
        Dermatol Surg. 1997; 23: 657-662
        • Nelson JS
        • Geronemus RG.
        Redarkening of port-wine stains 10 years after laser treatment.
        N Engl J Med. 2007; 356 (author reply 2746): 2745-2746
        • Anolik R
        • Newlove T
        • Weiss ET
        • et al.
        Investigation into optimal treatment intervals of facial port-wine stains using the pulsed dye laser.
        J Am Acad Dermatol. 2012; 67: 985-990
        • Tan OT
        • Sherwood K
        • Gilchrest BA.
        Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser.
        N Engl J Med. 1989; 320: 416-421
        • Nelson JS
        • Applebaum J.
        Clinical management of port-wine stain in infants and young children using the flashlamp-pulsed dye laser.
        Clin Pediatr (Phila). 1990; 29 ([discussion: 509]): 503-508
        • Renfro L
        • Geronemus RG.
        Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser.
        Arch Dermatol. 1993; 129: 182-188
        • Nguyen CM
        • Yohn JJ
        • Huff C
        • Weston WL
        • Morelli JG.
        Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser.
        Br J Dermatol. 1998; 138: 821-825
        • Morelli JG
        • Weston WL
        • Huff JC
        • Yohn JJ.
        Initial lesion size as a predictive factor in determining the response of port-wine stains in children treated with the pulsed dye laser.
        Arch Pediatr Adolesc Med. 1995; 149: 1142-1144
        • Lanigan SW.
        Port wine stains on the lower limb: response to pulsed dye laser therapy.
        Clin Exp Dermatol. 1996; 21: 88-92
        • Khandpur S
        • Sharma VK.
        Assessment of efficacy of the 595-nm pulsed dye laser in the treatment of facial port-wine stains in Indian patients.
        Dermatol Surg. 2016; 42: 717-726
        • Bae YS
        • Ng E
        • Geronemus RG.
        Successful treatment of two pediatric port wine stains in darker skin types using 595 nm laser.
        Lasers Surg Med. 2016; 48: 339-342
        • Yu W
        • Zhu J
        • Changc SJ
        • et al.
        Shorter treatment intervals of East Asians with port-wine stain with pulsed dye laser are safe and effective-a prospective side-by-side comparison.
        Photomed Laser Surg. 2018; 36: 37-43
        • Chapas AM
        • Eickhorst K
        • Geronemus RG.
        Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases.
        Lasers Surg Med. 2007; 39: 563-568
        • Geronemus RG
        • Quintana AT
        • Lou WW
        • Kauvar AN.
        High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy.
        Arch Dermatol. 2000; 136: 942-943
        • Geronemus RG.
        Pulsed dye laser treatment of vascular lesions in children.
        J Dermatol Surg Oncol. 1993; 19: 303-310
        • Ashinoff R
        • Geronemus RG.
        Flashlamp-pumped pulsed dye laser for port-wine stains in infancy: earlier versus later treatment.
        J Am Acad Dermatol. 1991; 24: 467-472
        • Barsky SH
        • Rosen S
        • Geer DE
        • Noe JM.
        The nature and evolution of port wine stains: a computer-assisted study.
        J Invest Dermatol. 1980; 74: 154-157
        • Nagore E
        • Requena C
        • Sevila A
        • et al.
        Thickness of healthy and affected skin of children with port wine stains: potential repercussions on response to pulsed dye laser treatment.
        Dermatol Surg. 2004; 30: 1457-1461
        • Fiskerstrand EJ
        • Svaasand LO
        • Kopstad G
        • Dalaker M
        • Norvang LT
        • Volden G.
        Laser treatment of port wine stains: therapeutic outcome in relation to morphological parameters.
        Br J Dermatol. 1996; 134: 1039-1043
        • Hagen SL
        • Grey KR
        • Korta DZ
        • Kelly KM.
        Quality of life in adults with facial port-wine stains.
        J Am Acad Dermatol. 2017; 76: 695-702
        • Lanigan SW
        • Cotterill JA.
        Psychological disabilities amongst patients with port wine stains.
        Br J Dermatol. 1989; 121: 209-215
        • Augustin M
        • Zschocke I
        • Wiek K
        • Peschen M
        • Vanscheidt W.
        Psychosocial stress of patients with port wine stains and expectations of dye laser treatment.
        Dermatology. 1998; 197: 353-360
        • Troilius A
        • Wrangsjö B
        • Ljunggren B.
        Patients with port-wine stains and their psychosocial reactions after photothermolytic treatment.
        Dermatol Surg. 2000; 26: 190-196
        • Shakespeare V
        • Shakespeare P
        • Cole RP.
        Measuring patient satisfaction with pulsed dye laser treatment of vascular lesions.
        Lasers Med Sci. 1998; 13: 253-259
      2. Administration UFaD. FDA Drug Safety Communication: FDA approves label changes for use of general anesthetic and sedation drugs in young children. 2017. Available at: Accessed April 9, 2020.

        • Warner DO
        • Zaccariello MJ
        • Katusic SK
        • et al.
        Neuropsychological and behavioral outcomes after exposure of young children to procedures requiring general anesthesia: the Mayo Anesthesia Safety in Kids (Mask) Study.
        Anesthesiology. 2018; 129: 89-105
        • Sprung J
        • Flick RP
        • Katusic SK
        • et al.
        Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia.
        Mayo Clin Proc. 2012; 87: 120-129
        • Hu D
        • Flick RP
        • Zaccariello MJ
        • et al.
        Association between exposure of young children to procedures requiring general anesthesia and learning and behavioral outcomes in a population-based birth cohort.
        Anesthesiology. 2017; 127: 227-240
        • Flick RP
        • Katusic SK
        • Colligan RC
        • et al.
        Cognitive and behavioral outcomes after early exposure to anesthesia and surgery.
        Pediatrics. 2011; 128: e1053-e1061
        • Banerjee P
        • Rossi MG
        • Anghelescu DL
        • et al.
        Association between anesthesia exposure and neurocognitive and neuroimaging outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
        JAMA Oncol. 2019; 5: 1456-1463
        • Anand KJ
        • Hickey PR.
        Pain and its effects in the human neonate and fetus.
        N Engl J Med. 1987; 317: 1321-1329
        • Grunau R.
        Early pain in preterm infants. A model of long-term effects.
        Clin Perinatol. 2002; 29 (vii-viii): 373-394
        • Haydar B
        • Gray H
        • Holman A.
        Avoiding general anesthesia in treating port-wine stains in infants to avoid neurotoxic events: risk-benefit ratio still undefined.
        JAMA Dermatol. 2019; 155: 983-984
        • Geronemus RG
        • Jeon H
        • Bernstein LJ.
        Avoiding general anesthesia in treating port-wine stains in infants to avoid neurotoxic events-reply.
        JAMA Dermatol. 2019; 155: 984
        • Shih S
        • Khachemoune A.
        Use of eye shields for mohs micrographic surgery of the eyelids and periorbital area.
        Dermatol Surg. 2019; 45: 210-215
        • Ogle CA
        • Shim EK
        • Godwin JA.
        Use of eye shields and eye lubricants among oculoplastic and Mohs surgeons: a survey.
        J Drugs Dermatol. 2009; 8: 855-860
        • Ries WR
        • Clymer MA
        • Reinisch L.
        Laser safety features of eye shields.
        Lasers Surg Med. 1996; 18: 309-315
        • Chowdhury MM
        • Harris S
        • Lanigan SW.
        Potassium titanyl phosphate laser treatment of resistant port-wine stains.
        Br J Dermatol. 2001; 144: 814-817
        • Woo WK
        • Jasim ZF
        • Handley JM.
        Evaluating the efficacy of treatment of resistant port-wine stains with variable-pulse 595-nm pulsed dye and 532-nm Nd:YAG lasers.
        Dermatol Surg. 2004; 30 ([discussion: 162]): 158-162
        • Brauer JA
        • Geronemus RG.
        Single-treatment resolution of vascular blebs within port wine stains using a novel 1,064-nm neodymium-doped yttrium aluminum garnet laser.
        Dermatol Surg. 2013; 39: 1113-1115
        • Izikson L
        • Nelson JS
        • Anderson RR.
        Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients.
        Lasers Surg Med. 2009; 41: 427-432
        • Stier MF
        • Glick SA
        • Hirsch RJ.
        Laser treatment of pediatric vascular lesions: port wine stains and hemangiomas.
        J Am Acad Dermatol. 2008; 58: 261-285
        • Seukeran DC
        • Collins P
        • Sheehan-Dare RA.
        Adverse reactions following pulsed tunable dye laser treatment of port wine stains in 701 patients.
        Br J Dermatol. 1997; 136: 725-729
        • Kelly KM
        • Nanda VS
        • Nelson JS.
        Treatment of port-wine stain birthmarks using the 1.5-msec pulsed dye laser at high fluences in conjunction with cryogen spray cooling.
        Dermatol Surg. 2002; 28: 309-313
        • Alster TS
        • Tanzi EL.
        Combined 595-nm and 1,064-nm laser irradiation of recalcitrant and hypertrophic port-wine stains in children and adults.
        Dermatol Surg. 2009; 35 ([discussion: 918-919]): 914-918
        • Bae YC
        • Alabdulrazzaq H
        • Brauer JA
        • Geronemus RG.
        Treatment of recalcitrant port-wine stains (PWS) using a combined pulsed dye laser (PDL) and radiofrequency (RF) energy device.
        J Am Acad Dermatol. 2017; 76: 321-326
        • Phung TL
        • Oble DA
        • Jia W
        • Benjamin LE
        • Mihm Jr, MC
        • Nelson JS.
        Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks.
        Lasers Surg Med. 2008; 40: 1-5
        • Zhang Y
        • Zou X
        • Chen H
        • Yang Y
        • Lin H
        • Guo X.
        Clinical study on clinical operation and post-treatment reactions of HMME-PDT in treatment of PWS.
        Photodiagnosis Photodyn Ther. 2017; 20: 253-256
        • Li-Qiang G
        • Hua W
        • Si-Li N
        • Chun-Hua T.
        A clinical study of HMME-PDT therapy in Chinese pediatric patients with port-wine stain.
        Photodiagnosis Photodyn Ther. 2018; 23: 102-105
        • Zhang Y
        • Yang Y
        • Zhang Z
        • et al.
        Clinical study on hemoporfin PDT for infant facial port-wine stains.
        Photodiagnosis Photodyn Ther. 2019; 25: 106-110
        • D'Angelo G
        • Lee H
        • Weiner RI.
        cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.
        J Cell Biochem. 1997; 67: 353-366
        • Passeron T
        • Maza A
        • Fontas E
        • et al.
        Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial.
        Br J Dermatol. 2014; 170: 1350-1353
        • Sauder DN.
        Immunomodulatory and pharmacologic properties of imiquimod.
        J Am Acad Dermatol. 2000; 43: S6-11
        • Chang CJ
        • Hsiao YC
        • Mihm Jr, MC
        • Nelson JS.
        Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.
        Lasers Surg Med. 2008; 40: 605-610
        • Tremaine AM
        • Armstrong J
        • Huang YC
        • et al.
        Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod.
        J Am Acad Dermatol. 2012; 66: 634-641
        • Sklar LR
        • Burnett CT
        • Waibel JS
        • Moy RL
        • Ozog DM.
        Laser assisted drug delivery: a review of an evolving technology.
        Lasers Surg Med. 2014; 46: 249-262
        • Gao L
        • Phan S
        • Nadora DM
        • et al.
        Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways.
        Lasers Surg Med. 2014; 46: 679-688
        • Marqués L
        • Núñez-Córdoba JM
        • Aguado L
        • et al.
        Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.
        J Am Acad Dermatol. 2015; 72 (.e1): 151-158
        • Greveling K
        • Prens EP
        • van Doorn MB.
        Treatment of port wine stains using pulsed dye laser, erbium yag laser, and topical rapamycin (sirolimus)-a randomized controlled trial.
        Lasers Surg Med. 2017; 49: 104-109
        • Doh EJ
        • Ohn J
        • Kim MJ
        • Kim YG
        • Cho S.
        Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation.
        J Dermatolog Treat. 2017; 28: 672-677
        • Artzi O
        • Mehrabi JN
        • Heyman L
        • Friedman O
        • Mashiah J.
        Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application.
        Dermatol Ther. 2020; 33: e13172
      3. Christman MP, Feng H, Holmes J, Geronemus RG. Treating port wine stain birthmarks using dynamic optical coherence tomography-guided settings [e-pub ahead of print]. J Am Acad Dermatol. doi:10.1016/j.jaad.2019.08.028. Accsessed April, 2020.